BSIM Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 6

BSIM Therapeutics General Information

Description

Operator of a drug discovery platform intended to fight neurodegenerative amyloid diseases. The company's platform focuses on the design of organ-targeted, high-quality drug candidates for the treatment of transthyretin-mediated amyloidoses, enabling patients to improve their lives affected by this disease through innovative therapeutic approaches.

Contact Information

Website
www.bsimtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Instituto Pedro Nunes
  • Rua Pedro Nunes, Edifício C, Sala 2.15
  • Coimbra, 3030-199
  • Portugal
+351 239 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BSIM Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 00000 Completed Generating Revenue
4. Accelerator/Incubator 00000 Completed Generating Revenue
3. Accelerator/Incubator 10-Jun-2019 00000 Completed Generating Revenue
2. Seed Round 23-Dec-2016 $581K $581K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view BSIM Therapeutics’s complete valuation and funding history, request access »

BSIM Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Rui Brito Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Carlos Simoes Ph.D Co-Founder, Chief Technology Officer & Board Member
To view BSIM Therapeutics’s complete executive team members history, request access »

BSIM Therapeutics Board Members (3)

Name Representing Role Since
Carlos Simoes Ph.D BSIM Therapeutics Co-Founder, Chief Technology Officer & Board Member 000 0000
Eric Leire MD Self Board Member 000 0000
Raúl Saraiva BSIM Therapeutics Board Member 000 0000
To view BSIM Therapeutics’s complete board members history, request access »

BSIM Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BSIM Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest Horizon Government 000 0000 000000 0
A2b (Coimbra) Angel Group Minority 000 0000 000000 0
Portugal Ventures Venture Capital Minority 000 0000 000000 0
Bluepharma - Indústria Farmacêutica Corporation Minority 000 0000 000000 0
Building Global Innovators Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »